You are currently browsing the archives for 4 February 2018.
Displaying 1 entry.

Breakthrough in prenatal screening for Straight down syndrome Lenetix.

Today announced a substantial part of the development of a better initial and second trimester noninvasive fetal chromosomal screening check to detect Down syndrome and additional genetic fetal circumstances. Lenetix presented preliminary research results at the 29th annual Culture for Maternal-Fetal Medicine Meeting in NORTH PARK that indicate a potential breakthrough in tests quality and precision while preserving the protection of mom and fetus. The maternal serum test produced by Lenetix medical director Dr.